Table 1—

Comparison of demographic and clinical characteristics among severe sepsis patients with community-acquired pneumonia who received initial macrolide versus non-macrolide therapy

VariableNon-macrolideMacrolidep-value
Patients n133104
Age yrs63.3±17.158.8±15.80.2
Male109 (82.0)80 (76.9)0.3
Pre-existing comorbid conditions
 Congestive heart failure34 (25.6)19 (18.3)0.2
 History of stroke30 (22.6)8 (7.7)0.002
 Chronic liver disease17 (12.8)11 (10.6)0.6
 History of malignancy18 (13.5)7 (6.5)0.09
 Renal insufficiency34 (25.6)14 (13.5)0.02
 Chronic obstructive lung disease39 (29.3)22 (21.2)0.2
History, physical, laboratory and radiographical data
 Altered mental status36 (27.1)32 (30.8)0.5
 Respiratory rate >30 min−119 (14.3)14 (13.5)0.2
 Systolic blood pressure <90 mmHg8 (6.0)8 (7.7)0.6
 Cardiac frequency >125 min−125 (18.8)19 (18.3)0.9
 Temperature <95°F or >104°F3 (2.3)3 (2.9)0.8
 Arterial pH <7.3519 (14.3)18 (17.3)0.5
 Pa,O2 <90%39 (29.3)42 (40.4)0.07
 Pa,O2/Fi,O2 ratio ≤25051 (38.4)60 (57.7)0.07
 Haematocrit <30%12 (9.0)14 (13.5)0.3
 Serum blood urea nitrogen >30 mg·dL−175 (56.4)49 (47.1)0.2
 Serum glucose >250 mg·dL−120 (15.0)13 (12.5)0.6
 Serum sodium <130 mEq·L−118 (13.5)26 (25.0)0.02
 Pleural effusion36 (27.1)30 (28.8)0.8
 Multilobar infiltrates58 (43.9)55 (52.9)0.2
Processes of care measures
 Appropriate blood cultures108 (81.20)86 (82.7)0.8
 Guideline-concordant antibiotic therapy84 (63.2)101 (97.1)<0.001
 Antibiotic administration within 4 h39 (29.3)37 (35.6)0.3
  • Data are presented as mean±sd or n (%), unless otherwise stated. Pa,O2: arterial oxygen tension; Fi,O2: inspiratory oxygen fraction.